Aridis Pharmaceuticals, Inc. - Common Stock (ARDS)

CUSIP: 040334104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
44,586,623
Total 13F shares
1,868,871
Share change
-53,030
Total reported value
$2,053,275
Price per share
$1.10
Number of holders
19
Value change
-$95,897
Number of buys
7
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 040334104?
CUSIP 040334104 identifies ARDS - Aridis Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q2 2022

As of 30 Jun 2022, Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,868,871 shares. The largest 10 holders included COMMONWEALTH EQUITY SERVICES, LLC, VANGUARD GROUP INC, Roumell Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Minot Wealth Management LLC, STATE STREET CORP, GROUP ONE TRADING, L.P., CITADEL ADVISORS LLC, BlackRock Inc., and NORTHERN TRUST CORP. This page lists 19 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.